---
document_datetime: 2023-09-21 17:06:47
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/zoledronic-acid-actavis-epar-all-authorised-presentations_en.pdf
document_name: zoledronic-acid-actavis-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.803482
conversion_datetime: 2025-12-28 12:26:40.336518
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name                    | Strength   | Pharmaceutical Form                   | Route of Administration   | Packaging      | Package size   |
|-----------------|-------------------------|------------|---------------------------------------|---------------------------|----------------|----------------|
| EU/1/12/759/001 | Zoledronic acid Actavis | 4 mg/5 ml  | Concentrate for solution for infusion | Intravenous use           | Vial (plastic) | 1 vial         |
| EU/1/12/759/002 | Zoledronic acid Actavis | 4 mg/5 ml  | Concentrate for solution for infusion | Intravenous use           | Vial (plastic) | 4 vials        |
| EU/1/12/759/003 | Zoledronic acid Actavis | 4 mg/5 ml  | Concentrate for solution for infusion | Intravenous use           | Vial (plastic) | 10 vials       |